Understanding the Anticancer Effects of Phytochemicals: From Molecular Docking to Anticarcinogenic Signaling

Fuwei Tian1, Shuhong Sun1, Zehe Ge1

  • 1Department of Nutrition and Food Hygiene, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.

The Journal of Nutrition
|November 24, 2024
PubMed

Insights

Phytochemicals show anticancer benefits by targeting cancer signaling pathways. Molecular docking reveals plant chemical targets, aiding in designing new cancer treatments.

Area of Science:

  • Phytochemical research
  • Cancer biology
  • Molecular pharmacology

Background:

  • Phytochemicals, recognized for antioxidant and anti-inflammatory properties, exhibit anticancer effects.
  • While general anticancer benefits are known, specific molecular targets and pathways remain under investigation.
  • Understanding phytochemicals' interactions with cancer-related signaling pathways is crucial.

Purpose of the Study:

  • To review potential signaling pathways targeted by phytochemicals in cancer.
  • To elucidate the molecular mechanisms behind phytochemicals' anticancer effects.
  • To guide the development of novel cancer therapies based on phytochemicals.

Main Methods:

  • Literature review of phytochemical biological activities.
  • Analysis of molecular docking simulations identifying phytochemical-target interactions.
  • Synthesis of current research on phytochemicals and cancer signaling.

Main Results:

  • Phytochemicals interact with multiple cancer-related signaling pathways.
  • Molecular docking has identified numerous cellular target molecules for phytochemicals.
  • Evidence suggests phytochemicals can modulate pathways involved in cell proliferation, apoptosis, and inflammation.

Conclusions:

  • Phytochemicals offer a promising avenue for cancer treatment development.
  • Targeting specific binding sites and modes of phytochemicals can enhance therapeutic efficacy.
  • Further research into phytochemical-cancer pathway interactions will accelerate drug discovery.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.1K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K